Actualités Oncology Institute Inc - TOI | Actions NASDAQ

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 SCHEDULE 14AProxy Statement Pursuant to Section 14(a...

Amended Current Report Filing (8-k/a)

0001799191false00017991912023-06-082023-06-080001799191us-gaap:CommonStockMember2023-06-082023-06-080001799191us-gaap:WarrantMember2023-06-082023-0...

Current Report Filing (8-k)

0001799191false00017991912023-06-112023-06-110001799191us-gaap:CommonStockMember2023-06-112023-06-110001799191us-gaap:WarrantMember2023-06-112023-0...

The Oncology Institute Announces Leadership Transition

CERRITOS, Calif., June 12, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the...

The Oncology Institute (TOI) and Massive Bio Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research

CERRITOS, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute (NASDAQ: TOI), has announced a...

The Oncology Institute to Open Project Southland

CERRITOS, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute (NASDAQ: TOI), has announced a...

The Oncology Institute Featured on Four Abstracts at ASCO 2023 Annual Meeting

CERRITOS, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute (NASDAQ: TOI), one of the largest...

The Oncology Institute to Participate at Upcoming Investor Conferences

CERRITOS, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the...

Current Report Filing (8-k)

0001799191false00017991912023-05-192023-05-190001799191us-gaap:CommonStockMember2023-05-192023-05-190001799191us-gaap:WarrantMember2023-05-192023-0...

Quarterly Report (10-q)

0001799191--12-312023Q1FALSE00017991912023-01-012023-03-310001799191us-gaap:CommonStockMember2023-01-012023-03-310001799191us-gaap:WarrantMember202...

Current Report Filing (8-k)

0001799191false00017991912023-05-102023-05-100001799191us-gaap:CommonStockMember2023-05-102023-05-100001799191us-gaap:WarrantMember2023-05-102023-0...

The Oncology Institute Reports First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance

CERRITOS, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the...

The Oncology Institute Announces a Strategic Partnership with IDEOlogy Health to Provide Customized Medical Education

The Oncology Institute Announces a Strategic Partnership with IDEOlogy Health to Provide Customized Medical Education PR Newswire CERRITOS...

TOI Patient is First Worldwide to be Treated with Promising Therapy for Metastatic Ovarian Cancer

CERRITOS, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- A new era of immunotherapy-based treatments for metastatic...

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Oncology Institute Inc (TOI)

Votre Hub pour des idées et discussions en direct en temps réel

TOI Actualités

Additional Proxy Soliciting Materials (definitive) (defa14a)

Amended Current Report Filing (8-k/a)

Current Report Filing (8-k)

The Oncology Institute Announces Leadership Transition

The Oncology Institute (TOI) and Massive Bio Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research

The Oncology Institute to Open Project Southland

The Oncology Institute Featured on Four Abstracts at ASCO 2023 Annual Meeting

The Oncology Institute to Participate at Upcoming Investor Conferences

Current Report Filing (8-k)

Quarterly Report (10-q)

Current Report Filing (8-k)

The Oncology Institute Reports First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance

The Oncology Institute Announces a Strategic Partnership with IDEOlogy Health to Provide Customized Medical Education

TOI Patient is First Worldwide to be Treated with Promising Therapy for Metastatic Ovarian Cancer

Additional Proxy Soliciting Materials (definitive) (defa14a)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Oncology Institute Inc (TOI) Actualités

Oncology Institute Inc (TOI)

Votre Hub pour des idées et discussions en direct en temps réel

TOI Actualités

Additional Proxy Soliciting Materials (definitive) (defa14a)

Amended Current Report Filing (8-k/a)

Current Report Filing (8-k)

The Oncology Institute Announces Leadership Transition

The Oncology Institute (TOI) and Massive Bio Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research

The Oncology Institute to Open Project Southland

The Oncology Institute Featured on Four Abstracts at ASCO 2023 Annual Meeting

The Oncology Institute to Participate at Upcoming Investor Conferences

Current Report Filing (8-k)

Quarterly Report (10-q)

Current Report Filing (8-k)

The Oncology Institute Reports First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance

The Oncology Institute Announces a Strategic Partnership with IDEOlogy Health to Provide Customized Medical Education

TOI Patient is First Worldwide to be Treated with Promising Therapy for Metastatic Ovarian Cancer

Additional Proxy Soliciting Materials (definitive) (defa14a)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités